The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Subscribe To Our Newsletter & Stay Updated
